The role of povidone and cadexomer iodine in the management of acute and chronic wounds

References

• Smith RG. A critical discussion of the use of antiseptics in acute traumatic wounds. J Am Podiatr Med Assoc. 2005;95:148–53.
   PubMed Web of Science ®Google Scholar
• Brennan SS, Leaper DJ. The effect of antiseptics on the healing wound: a study using the rabbit ear chamber. Br J Surg. 1985;72:780–2.
   PubMed Web of Science ®Google Scholar
• Khan MN, Naqvi AH. Antiseptics, iodine, povidone iodine and traumatic wound cleansing. J Tissue Viability. 2006;16:6–10.
   PubMedGoogle Scholar
• Morison MJ. Wound cleansing — which solution? Professional Nurse. 1989;4:220–5.
   PubMedGoogle Scholar
• McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147–79.
   PubMed Web of Science ®Google Scholar
• Selvaggi G, Monstrey S, Van Landuyt K, Hamdi M, Blondeel P. The role of iodine in antisepsis and wound management: a reappraisal. Acta Chir Belg. 2003;103:241–7.
   PubMed Web of Science ®Google Scholar
• Flynn J. Povidone-iodine as a topical antiseptic for treating and preventing wound infection: a literature review. Br J Community Nurs. 2003;8:36–42.
   PubMedGoogle Scholar
• Cooper RA. Iodine revisited. Int Wound J. 2007;4:124–37.
   PubMedGoogle Scholar
• Landis SJ. Chronic wound infection and antimicrobial use. Adv Skin Wound Care. 2008;21:531–40.
   PubMedGoogle Scholar
• Gottardi W. The influence of the chemical behaviour of iodine on the germicidal action of disinfectant solutions containing iodine. J Hosp Infect. 1985;6 Suppl A:1–11.
   PubMedGoogle Scholar
• Reimer K, Schreier H, Erdos G, Konig B, Konig W, Fleischer W. Molecular effects of a microbicidal substance on relevant microorganisms: electron microscopic and biochemical studies on povidone-iodine. Int J Hyg Environ Med. 1998;200:423–34.
   Google Scholar
• Schreier H, Erdos G, Reimer K, Konig B, Konig W, Fleischer W. Molecular effects of povidone-iodine on relevant microorganisms: an electron-microscopic and biochemical study. Dermatology. 1997;195 Suppl 2:111–6.
   PubMedGoogle Scholar
• Scherr DD, Dodd TA. In vitro bacteriological evaluation of the effectiveness of antimicrobial irrigating solutions. J Bone Joint Surg. 1976;58:119–22.
   PubMed Web of Science ®Google Scholar
• Kunisada T, Yamada K, Oda S, Hara O. Investigation on the efficacy of povidone-Iodine against antiseptic-resistant species. Dermatology. 1997;195 Suppl 2:14–8.
   PubMedGoogle Scholar
• Goldenheim PD. In vitro efficacy of povidone-iodine solution and cream against methicillin-resistant Staphylococcus aureus. Postgrad Med J. 1993;69 Suppl 3:S62–5.
   PubMedGoogle Scholar
• McLure AR, Gordon J. In-vitro evaluation of povidone-iodine and chlorhexidine against methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1992;21:291–9.
   PubMed Web of Science ®Google Scholar
• Lawrence JC. A povidone-iodine medicated dressing. J Wound Care. 1998;7:332–6.
   PubMedGoogle Scholar
• Thomas S, Dawes CE, Hay NP. Improvements in medicated tulle dressings. J Hosp Infect. 1983;4:391–8.
   PubMed Web of Science ®Google Scholar
• Close-Tweedie J. The role of povidone-iodine in podiatric chronic wound care. J Wound Care. 2001;10:339–42.
   PubMedGoogle Scholar
• Sindelar WF, Mason GR. Irrigation of subcutaneous tissue with povidone-iodine solution for prevention of surgical wound infections. Surg Gynecol Obstet. 1979;148:227–31.
   PubMedGoogle Scholar
• Gravett A, Sterner S, Clinton JE, Ruiz E. A trial of povidone-iodine in the prevention of infection in sutured lacerations. Ann Emerg Med. 1987;16:167–71.
   PubMed Web of Science ®Google Scholar
• DeKock M, Van Der Merwe AE, Swarts C. A comparative study of povidone iodine cream and silver sulfadiazine in the topical treatment of burns. Wounds. 1989;1:65–71.
   Google Scholar
• Jurczak F, Dugré T, Johnstone A, Offori T, Vujovic Z, Hollander D. Randomised clinical trial of Hydrofiber dressing with silver versus povidone-iodine gauze in the management of open surgical and traumatic wounds. Int Wound J. 2007;4:66–76.
   PubMedGoogle Scholar
• Fournel I, Tiv M, Soulias M, Hua C, Astruc K, Aho Glele LS. Meta-analysis of intraoperative povidone-iodine application to prevent surgical-site infection. Br J Surg. 2010;97:1603–13.
   PubMed Web of Science ®Google Scholar
• Gordon MWG, Aikman L, Little K, Luke C. Prevention of wound infection in the accident and emergency department: does povidone iodine dry powder spray reduce infection rates? J Accid Emerg Med. 1989;4:11–3.
   Google Scholar
• Burks RI. Povidone-iodine solution in wound treatment. Phys Ther. 1998;78:212–8.
   PubMed Web of Science ®Google Scholar
• Lammers RL, Fourre M, Callaham ML, Boone T. Effect of povidone-iodine and saline soaking on bacterial counts in acute, traumatic, contaminated wounds. Ann Emerg Med. 1990;19:709–14.
   PubMed Web of Science ®Google Scholar
• Viljanto J. Disinfection of surgical wounds without inhibition of normal wound healing. Arch Surg. 1980;115:253–6.
   PubMedGoogle Scholar
• Rackur H. New aspects of mechanism of action of povidone-iodine. J Hosp Infect. 1985;6 Suppl A:13–23.
   PubMedGoogle Scholar
• Rodeheaver G, Bellamy W, Kody M. Bactericidal activity and toxicity of iodine-containing solutions in wounds. Arch Surg. 1982;117:181–6.
   PubMedGoogle Scholar
• Mertz PM, Alvarez OM, Smerbeck RV, Eaglstein WH. A new in vivo model for the evaluation of topical antiseptics on superficial wounds. The effect of 70% alcohol and povidone-iodine solution. Arch Dermatol. 1984;120:58–62.
   PubMedGoogle Scholar
• Hill KE, Malic S, McKee R, Rennison T, Harding KG, Williams DW, et al.. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptabilities. J Antimicrob Chemother. 2010;65:1196–206.
   Google Scholar
• Akiyama H, Oono T, Saito M, Iwatsuki K. Assessment of cadexomer iodine against Staphylococcus aureus biofilm in vivo and in vitro using confocal laser scanning microscopy. J Dermatol. 2004;31:529–34.
   PubMed Web of Science ®Google Scholar
• Bradshaw CE. An in vitro comparison of the antimicrobial activity of honey, iodine and silver wound dressings. Biosci Horizons. 2011;4:61–70.
   Google Scholar
• Mertz PM, Oliveira-Gandia MF, Davis SC. The evaluation of a cadexomer iodine wound dressing on methicillin resistant Staphylococcus aureus (MRSA) in acute wounds. Dermatol Surg. 1999;25:89–93.
   PubMed Web of Science ®Google Scholar
• Skog E, Arnesjo B, Troeng T, Gjöres JE, Bergljung L, Gundersen J, et al.. A randomised trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers. Br J Dermatol. 1983;109:77–83.
   PubMed Web of Science ®Google Scholar
• Danielsen L, Cherry GW, Harding K, Rollman O. Cadexomer iodine in ulcers colonised by Pseudomonas aeruginosa. J Wound Care. 1997;6:169–72.
   PubMedGoogle Scholar
• Ormiston MC, Seymour MT, Venn GE, Cohen RI, Fox JA. Controlled trial of Iodosorb in chronic venous ulcers. Br Med J. 1985;291:308–10.
   PubMedGoogle Scholar
• Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579–87.
   PubMed Web of Science ®Google Scholar
• Livermore DM. Minimising antibiotic resistance. Lancet Infect Dis. 2005;5:450–9.
   PubMed Web of Science ®Google Scholar
• Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128:1037–50.
   PubMed Web of Science ®Google Scholar
• Sibbald RG, Leaper DJ, Queen D. Iodine made easy. Wounds Int. 2011;2 Suppl 2:1–6.
   Google Scholar
• Mycock G. Methicillin/antiseptic-resistant Staphylococcus aureus. Lancet. 1985;2:949–50.
   PubMed Web of Science ®Google Scholar
• Lacey RW, Catto A. Action of povidone-iodine against methicillin-sensitive and -resistant cultures of Staphylococcus aureus. Postgrad Med J. 1993;69 Suppl 3:S78–83.
   PubMedGoogle Scholar
• Houang ET, Gilmore OJ, Reid C, Shaw EJ. Absence of bacterial resistance to povidone iodine. J Clin Pathol. 1976;29:752–5.
   PubMed Web of Science ®Google Scholar
• Klossner BL, Widmer H, Frey F. Nondevelopment of resistance by bacteria during hospital use of povidone-lodine. Dermatology. 1997;195 Suppl 2:10–3.
   Google Scholar
• Yasuda T, Yoshimura Y, Takada H, Kawaguchi S, Ito M, Yamazaki F, et al.. Comparison of bactericidal effects of commonly used antiseptics against pathogens causing nosocomial infections. Part 2. Dermatology. 1997;195 Suppl 2:19–28.
   PubMedGoogle Scholar
• Rutala WA, Stiegel MM, Sarubbi FA, Weber DJ. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants. Infect Control Hosp Epidemiol. 1997;18:417–21.
   PubMed Web of Science ®Google Scholar
• Giacometti A, Cirioni O, Greganti G, Fineo A, Ghiselli R, Prete Del, et al.. Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2002;21:553–6.
   PubMed Web of Science ®Google Scholar
• Balin AK, Pratt L. Dilute povidone-iodine solutions inhibit human skin fibroblast growth. Dermatol Surg. 2002;28:210–4.
   PubMed Web of Science ®Google Scholar
• Cooper ML, Laxer JA, Hansbrough JF. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma. 1991;31:775–84.
   PubMed Web of Science ®Google Scholar
• Van den Broek PJ, Buys LF, Van Furth R. Interaction of povidone-iodine compounds, phagocytic cells, and microorganisms. Antimicrob Agents Chemother. 1982;22:593–7.
   PubMed Web of Science ®Google Scholar
• McKenna PJ, Lehr GS, Leist P, Welling RE. Antiseptic effectiveness with fibroblast preservation. Ann Plast Surg. 1991;27:265–8.
   PubMed Web of Science ®Google Scholar
• Fumal I, Braham C, Paquet P, Franchimont C, Pierard GE. The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study. Dermatology. 2002;204 Suppl 1:70–4.
   PubMedGoogle Scholar
• Bennett LL, Rosenblum RS, Perlov C, Davidso JM, Barton RM, Nanney LB. An in vivo comparison of topical agents on wound repair. Plast Reconstr Surg. 2001;108:675–85.
   PubMed Web of Science ®Google Scholar
• Geronemus RG, Mertz PM, Eaglstein WH. Wound healing. The effects of topical antimicrobial agents. Arch Dermatol. 1979;115:1311–4.
   PubMedGoogle Scholar
• Kjolseth D, Frank JM, Barker JH, Anderson GL, Rosenthal AI, Acland RD, et al.. Comparison of the effects of commonly used wound agents on epithelialization and neovascularisation. J Am Coll Surg. 1994;179:305–12.
   PubMed Web of Science ®Google Scholar
• Eming SA, Smola-Hess S, Kurschat P, Hirche D, Krieg T, Smola H. A novel property of povidone-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J Invest Dermatol. 2006;126:2731–3.
   PubMed Web of Science ®Google Scholar
• Drosou A, Falabella A, Kirsner RS. Antiseptics on wounds: an area of controversy. Wounds. 2003;15:149–66.
   Web of Science ®Google Scholar
• Angel DE, Morey P, Storer JG, Mwipatayi BP. The great debate over iodine in wound care continues: a review of the literature. Wound Practice Res. 2008;16:6–21.
   Google Scholar
• Moore K, Thomas A, Harding KG. Iodine released from the wound dressing Iodosorb modulates the secretion of cytokines by human macrophages responding to bacterial lipopolysaccharide. Int J Biochem Cell Biol. 1997;29:163–71.
   PubMed Web of Science ®Google Scholar
• Leaper DJ, Durani P. Topical antimicrobial therapy of chronic wounds healing by secondary intention using iodine products. Int Wound J. 2008;5:361–8.
   PubMed Web of Science ®Google Scholar
• Lamme EN, Gustafsson TO, Middelkoop E. Cadexomer iodine shows stimulation of epidermal regeneration in experimental full thickness wounds. Arch Dermatol Res. 1998;290:18–24.
   PubMed Web of Science ®Google Scholar
• Knutson RA, Merbitz LA, Creekmore MA, Snipes HG. Use of sugar and povidone-iodine to enhance wound healing: five year’s experience. South Med J. 1981;74:1329–35.
   PubMed Web of Science ®Google Scholar
• Nakao H, Yamazaki M, Tsuboi R, Ogawa H. Mixture of sugar and povidone–iodine stimulates wound healing by activating keratinocytes and fibroblast functions. Arch Dermatol Res. 2006;298:175–82.
   PubMed Web of Science ®Google Scholar
• Pierard-Franchimont C, Paquet P, Arrese JE, Pierard GE. Healing rate and bacterial necrotizing vasculitis in venous leg ulcers. Dermatology. 1997;194:383–7.
   PubMed Web of Science ®Google Scholar
• Vogt PM, Hauser J, Rossbach O, Bosse B, Fleischer W, Steinau H, et al.. Polyvinyl pyrrolidone-iodine liposome hydrogel improves epithelialization by combining moisture and antisepsis. A new concept in wound therapy. Wound Repair Regen. 2001;9:116–22.
   PubMed Web of Science ®Google Scholar
• Beukelman CJ, Hoekstra MJ, Uhl R, Reimer K, Mueller S. Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel®) for wound healing in vitro. Burns. 2008;34:845–55.
   PubMed Web of Science ®Google Scholar
• Steen M. Review of the use of povidone-iodine (PVP-I) in the treatment of burns. Postgrad Med J. 1993;69 Suppl 3:S84–92.
   PubMedGoogle Scholar
• Hunt JL, Sato R, Heck EL, Baxter CR. A critical evaluation of povidone-iodine absorption in thermally injured patients. J Trauma. 1980;20:127–9.
   PubMedGoogle Scholar
• Pietsch J, Meakins JL. Complications of povidone-iodine absorption in topically treated burn patients. Lancet. 1976;1:280–2.
   PubMed Web of Science ®Google Scholar
• Aronoff G, Friedman S, Diedens D, Lavelle K. Increased serum iodide concentration from iodine absorption through wounds treated topically with povidone-iodine. Am J Med Sci. 1980;279:173–6.
   PubMed Web of Science ®Google Scholar
• Shetty KR, Duthie J. Thyrotoxicosis induced by topical iodine application. Arch Intern Med. 1990;150:2400–1.
   PubMedGoogle Scholar
• D’auria JMD, Lipson SMD, Garfield JMMD. Fatal iodine toxicity following surgical debridement of a hip wound: case report. J Trauma Injury. 1990;30:353–5.
   PubMed Web of Science ®Google Scholar
• Reimer K, Vogt PM, Broegmann B, Hauser J, Rossbach O, Kramer A. An innovative topical drug formulation for wound healing and infection treatment; in vitro and in vivo investigations of a povidone iodine liposome hydrogel. Dermatology. 2000;201:235–41.
   PubMed Web of Science ®Google Scholar
• Nobukuni K, Hayakawa N, Namba R, Ihara Y, Sato K, Takada H, et al.. The influence of long-term treatment with povidone iodine on thyroid function. Dermatology. 1997;195 Suppl 2:69–72.
   PubMedGoogle Scholar
• Zellner PR, Bugyi S. Povidone-iodine in the treatment of burn patients. J Hosp Infect. 1985;6 Suppl A:139–46.
   PubMedGoogle Scholar
• Juhasz I. Experiences with the use of povidone-iodine-containing local therapeutics in dermatological surgery and in the treatment of burns: testing for allergic sensitization in postsurgery patients. Dermatology. 2002;204 Suppl 1:52–8.
   PubMedGoogle Scholar
• Lachapelle JM. Allergic contact dermatitis from povidone-iodine: a re-evaluation study. Contact Dermatitis. 2005;52:9–10.
   PubMed Web of Science ®Google Scholar
• Laudanska H, Gustavon B. IN- patients treatment of chronic varicose venous ulcers: a randomized trial of cadexomer-iodine versus standard dressing. J Int Med Res. 1988;16:428–35.
   PubMed Web of Science ®Google Scholar
• Holloway GA, Johansen KH, Barnes RW, Pierce GE. Multicenter trial of cadexomer iodine to treat venous stasis ulcers. Western J Med. 1989;151:35–8.
   PubMedGoogle Scholar
• Hansson C. The effects of cadexomer iodine paste in the treatment of venous leg ulcers compared with hydrocolloid dressing and paraffin gauze dressing. Int J Dermatol. 1998;37:390–6.
   PubMed Web of Science ®Google Scholar
• Bianchi J. Cadexomer-iodine in the treatment of venous leg ulcers: what is the evidence? J Wound Care. 2001;10:225–9.
   PubMedGoogle Scholar
• Floyer C, Wilkinson JD. Treatment of venous leg ulcers with cadexomer iodine with particular reference to iodine sensitivity. Acta Chi Scand. 1988;544 Suppl:60–1.
   Google Scholar
• Saap L, Fahim S, Arsenault E, Pratt M, Pierscianowski T, Falanga V, et al.. Contact sensitivity in patients with leg ulcerations, a North American study. Arch Dermatol. 2004;140:1241–6.
   PubMedGoogle Scholar
• British Medical Association. British National Formulary 57. London: BMJ Group and RPS Publishing; 2009. p. 57.
   Google Scholar